Gamida Cell Ltd.
Sector: Biotechnology - Therapeutics
Medical Field: Oncology
Technological Field: Regenerative Medicine - Stem Cell therapy
Year Established: 1998
Gamida-Cell is a leader in the expansion of stem cell therapeutics utilizing small molecules to stimulate stem cell self-renewal, with limited differentiation. Gamida Cell's technologies are simple, reversible, do not involve genetic interference, and are easily scalable.
Therapeutic stem cells are currently in clinical development for cancer and autoimmune diseases, as well as future regenerative cell-based medicines, including heart and pancreatic tissue repair. Gamida-Cell enjoys scientific collaboration with leading investigators, clinicians, and research groups around the world. StemEx(R), Gamida Cell's product in advanced clinical development for the treatment of hematological diseases, is being developed in a joint venture with Teva Pharmaceuticals. Gamida Cell has an additional product in advanced pre-clinical development for the treatment of heart disease.